Xanthomonas maltophilia - A growing problem in the haemodialysis population

Nephrology Dialysis Transplantation

Volumn 12, Issue 10, 1997, Pages 2174-2176

  Korzets, A ^a   Ori, Y ^a   Rudnicki, C ^a,b   Chagnac, A ^a   Weinstein, T ^a   Herman, M ^a   Zevin, D ^a   Gafter, U ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Central vein catheters; Haemodialysis; Xanthomonas maltophilia

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETER; FEMALE; GRAM NEGATIVE INFECTION; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; XANTHOMONAS;

EID: 0030815065     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.10.2174     Document Type: Article

References (19)

1. Bommer J. Medical complications of the long term dialysis patient. In: Cameron S, Davison AM, Grunfeld J, Kerr D, Ritz E (eds). Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, 1992; 1436-1458
2. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic haemodialysis adult patients in a multicentre prospective survey. Nephrol Dial Transplant 1995; 10: 377-381
3. Lowry PW, Beck-Sague CM, Bland LA, Aguero SM, Arduino MJ, Minuth AN. Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J Infect Dis 1990; 161: 85-90
4. Muder RR, Yu VL, Dummer JS, Vinson C, Lumish RM, Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch Intern Med 1987; 147: 1672-1674
5. Marshall WF, Keating MR, Anhalt JP, Steckelberg JM. Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc 1989; 64: 1097-1104
6. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-Aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 1990; 69: 296-306
7. Vartivarian SE, Papadakis KA, Palacios JA, Manning JT, Anaissie EJ. Mucocutaneous and soft tissue infections cuased by Xanthomonas maltophilia. Ann Intern Med 1994; 121: 969-973
8. Flaherty JP, Garcia-Houchias S, Chudy R, Arnow PM. An outbreak of Gram-negative bacteremia traced to contaminated O-rings in reprocessed dialysers. Ann Intern Med 1993; 119: 1072-1078
9. Roberts BW, Alvarado N, Garcia W, Solis Y, Lopez O, Duke CE. 'Header sepsis' syndrome: waterborne Xanthomonas-induced fevers. Dial Transplant 1994; 23; 464-471
10. Ganadu M, Mura GL, Campus AM et al. Relapsing pyrogenic reactions due to Xanthomonas maltophilia in a dialysis patient with a long-term central venous catheter. Nephrol Dial Transplant 1996; 11: 197-198
11. Spencer RC. The emergence of epidemic, multiple antibiotic-resistant Xanthomonas maltophilia and Pseudomonas cepacia. J Hosp Infect 1995; 30: 453-464
12. Villarino ME, Stevens LE, Schable B et al. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infect Control Hosp Epidemiol 1992; 13: 201-206
13. Smit WJ, Boquest AL, Geddes JE, Tosolini FA. The antibiotic susceptibilities to Xanthomonas maltophilia and their relation to clinical management. Pathology 1994; 26: 321-324
14. Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 1994; 38: 624-627
15. Garcia-Rodriguez JA, Fresnadillo MJ, Garcia-Garcia MI, Garcia- Sanchez E, Garcia-Sanchez JE, Trujillano I. Multicenter Spanish study of ciprofloxacin susceptibility in Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1995; 14: 456-459
16. Elting LS, Khiardoni N, Bodey G. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134-138
17. Cullmann W. Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates. Chemotherapy 1991; 37: 246-250
18. Stegeman CA, Cohen Tervaert JW, De Joup PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (cotrimoxazole) for the prevention of Wegener's granulomatosis. N Engl J Med 1996; 335: 16-20
19. Mandell GL, Sande MA. Antimicrobial agents. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds). The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, 1992; 1047-1064